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Abstract 
Periconceptional environment may influence embryo development, ultimately affecting adult health. 
Here, we review the rodent model of maternal low protein diet specifically during the preimplantation 
period (Emb-LPD) with normal nutrition during subsequent gestation and postnatally. This model, 
studied mainly in mouse, leads to cardiovascular, metabolic and behavioural disease in adult offspring 
with females more susceptible. We evaluate the sequence of events from diet administration that may 
lead to adult disease. Emb-LPD changes maternal serum and/or uterine fluid metabolite composition 
notably with reduced insulin and branched-chain amino acids (BCAAs). This is sensed by blastocysts 
through reduced mTORC1 signalling. Embryos respond by permanently changing the pattern of 
development of their extra-embryonic lineages, trophectoderm (TE) and primitive endoderm (PE), to 
enhance maternal nutrient retrieval during subsequent gestation. These compensatory changes include 
stimulation in proliferation, endocytosis and cellular motility and epigenetic mechanisms underlying 
them are being identified. Collectively, these responses act to protect fetal growth and likely contribute 
to offspring reproductive competitive fitness. However, the resulting growth adversely affects long-term 
health since perinatal weight positively correlates with adult disease risk. We argue that 
periconceptional environmental responses reflect developmental plasticity and ‘decisions’ made by 
embryos to optimise their own  development - but with lasting consequences. 
  
Introduction 
The discovery that adult health could be significantly affected by conditions in utero and early infancy 
first emerged with robust datasets from epidemiological research some 25 years ago, driven in 
particularly by Professor David Barker at Southampton UK (Barker, Osmond et al. 2009; Barker and 
Thornburg 2013). The Hertfordshire and Helsinki cohort studies demonstrated that risk factors for adult-
onset cardiovascular and metabolic disease, including coronary heart disease and type-2 diabetes, 
positively correlated with low birth weight and ‘catch-up’ growth in infancy. Such associations, also 
including neurological disease risk, are evident in males and females and have been replicated in 
different cohorts across the world (Barker and Thornburg 2013). The concept of fetal programming of 
non-communicable disease emerged from such studies, now known as the Developmental Origins of 
Health and Disease (DOHaD). Another critical human dataset that has been central in establishing the 
DOHaD hypothesis is from the Dutch Hunger Winter, a 5 month famine experienced during WW2 by 
the citizens of Amsterdam. Here, the effects of the famine experienced during gestation have revealed a 
similar elevated risk of cardiometabolic and neurological disease in later life than for pregnancies 
occurring outside the famine period (Roseboom, Painter et al. 2011). Human health is therefore 
critically dependent upon maternal provision of nutrients during pregnancy that influence fetal growth 
with lasting consequences. Research studies by any groups using animal models have searched for 
mechanisms of developmental programming to understand why the consequences of in utero 
environment might be so profound. There are some excellent reviews embracing rodent and larger 
animal models and considering the programming effects of both maternal undernutrition and 
overnutrition (Ford and Long 2011; Langley-Evans 2013; Langley-Evans 2014; Williams, Seki et al. 
2014; Zambrano, Guzman et al. 2014).  
 
A major theme to emerge from across these studies is that nutrition during pregnancy is indeed an 
environmental factor 70 that can activate physiological interactions between mother and conceptus, 
mediated through diverse mechanisms including hormonal signalling that may cause to epigenetic 
changes in  regulatory genes mechanisms within target tissues. Such interactions may modify placental 
efficiency, fetal growth and metabolic character, setting the foundation for disease when gestational and 
postnatal nutrient availability are discordant. Commonly, the physiological ‘markers’ of adult 
cardiometabolic dysfunction from across over- or under-nutritional models can be quite similar, with 
typically high blood pressure, poor glucose handling, increased adiposity and renal insufficiency all 
likely (Langley-Evans 2013). A second theme to emerge from animal models is the relevance of how 
different developmental stages may respond to a specific nutritional challenge in differing ways with the 
accumulative effects contributing to postnatal health (Langley-Evans, Welham et al. 1996). The 
periconceptional period has become recognised as a particularly vulnerable period for nutritional 
programming since maturing gametes and early embryos may show enduring  responses to 
environmental conditions due to the unique metabolic, epigenetic and developmental events associated 
with this reproductive stage (Fleming, Velazquez et al. 2012; MacLaughlin and McMillen 2007; Turner 
and Robker 2014; Zhang, Rattanatray et al. 2011) (see also later). In this context, it is apparent that 
paternal nutrition and physiology also contribute to developmental programming, either directly or 
indirectly through modulation of the maternal tract via the composition of the seminal plasma (Braun 
and Champagne 2014; Bromfield, Schjenken et al. 2014; Watkins and Sinclair 2014). 
 
The focus of this short review is to evaluate in mechanistic terms the effect of maternal low protein diet 
specifically during the periconceptional period on long-term health of offspring using our rodent 
models. We consider the adult phenotypic consequences but 95 go back in time to assess in a stepwise 
manner the likely sequence of events through changes in maternal body composition caused by diet, 
how the embryo may interface with these changes, and what the responses may be that lead to adverse 
developmental programming. Lastly, we consider broader consequences of periconceptional 
environment outside of nutritional influences that may affect adult health. 
 
Rodent maternal low protein diet and embryo programming 
The low protein diet (LPD) used in our lab comprises 9% casein as a protein source versus the control 
normal protein diet (NPD) which has 18% casein; other macro- and micronutrients have the same 
concentration except corn starch and sucrose which are elevated by ~14% in the LPD to ensure the two 
diets are isocaloric. The diet was formulated by Professor Alan Jackson’s laboratory in Southampton 
(Langley and Jackson 1994) and has been used extensively in rodent models of DOHaD by many 
laboratories worldwide (Langley-Evans 2013). It should be recognised that LPD at this protein 
concentration is a relatively mild restriction and would be a suitable nutrient base for a non-pregnant 
rodent; the effects of the diet can therefore be viewed as representative of potential variation across the 
normal range rather than an attempt to model starvation. Within our laboratory, we have used two 
maternal LPD treatments fed ad libitum, either from the time of detection of the copulatory plug in the 
morning after natural mating and for the duration of pregnancy (or late gestation prior to sacrifice for 
fetal/placental analyses; LPD) or exclusively from the time of detection of the copulatory plug until 
blastocyst formation (E4.25 rat; E3.5 mouse; Emb-LPD) before switching to NPD for the remainder of 
gestation (Figure 1). Control dams are fed NPD throughout gestation or until termination. During and 
after weaning, standard chow is provided for both experimental and control animals. The Emb-LPD diet 
offers the opportunity to assess the importance of the preimplantation period in nutritional 
programming. 
 
Long-term effects of maternal LPD and Emb-LPD: 
In both rat and mouse models, LPD and Emb-LPD had no effect on gestation length, litter size or the 
gender ratio of pups, reflecting the mild nature of the dietary challenge. In our original rat model 
(Kwong, Wild et al. 2000), Emb-LPD caused a slight decrease in birthweight in female offspring but 
was followed by more substantial and sustained increased growth in both male and female Emb-LPD 
offspring from weaning until 7 weeks of age. The stimulation in postnatal growth following Emb-LPD 
was coupled with increased mean systolic blood pressure in both male and female offspring but only 
significant in males at 4 and 11 weeks. Male Emb-LPD offspring also exhibited altered increased kidney 
and reduced liver/body weight ratios (Kwong, Wild et al. 2000). More detailed studies on rat Emb-LPD 
livers during fetal development demonstrated abnormality in expression of key genes in hepatic function 
comprising phosphoenolpyruvate carboxykinase (PEPCK, rate limiting enzyme for gluconeogenesis) in 
males and 11beta-hydroxysteroid dehydrogenase type 1 (a reductase for production of active 
glucocorticoid) in females (Kwong, Miller et al. 2007). Moreover, Emb-LPD fetal liver revealed 
abnormal imprinted gene expression in a gender specific manner (Kwong, Miller et al. 2006). 
 
Our studies in mice of long-term effects of Emb-LPD have been more detailed (Figure 2) but in general 
support and extend findings from the rat (Figure 2). Thus, a gender-influenced comorbidity of 
cardiovascular, metabolic and behavioural dysfunction is coupled with abnormal growth leading to late 
adult increased adiposity, with female offspring moreseverely affected (Watkins, Lucas et al. 2010; 
Watkins, Lucas et al. 2011; Watkins, Ursell et al. 2008). The cardiovascular disorder comprises a 
combination of physiological conditions evident for at least one year of postnatal life including relative 
hypertension present in both males and females and coupled with reduced capacity for arterial dilatation 
in response to isoprenaline, increased lung angiotensin-converting enzyme activity and, in females, 
reduced size of the heart, all factors that may contribute to the raised blood pressure (Watkins, Lucas et 
al. 2010; Watkins, Ursell et al. 2008). The Emb-LPD metabolic status in of Emb-LPD offspring, whilst 
not affecting serum glucose and insulin levels, reflected a change in adipose homeostasis with an 
increase (non-significant) in mean collective fat pad weight of over 20% in females coupled with 
increased gene expression of the insulin and IGF-1 receptors in retroperitoneal fat, suggestive of an 
energy-storage phenotype (Watkins, Lucas et al. 2011). The behavioural profile of Emb-LPD offspring 
was also compromised preferentially within females, evident within repeat open-field tests for 
locomotory activity and showing sustained hyperactivity but which may also be contributed by poorer 
memory (Watkins, Ursell et al. 2008). It should be further noted that the cardiovascular, metabolic and 
behavioural comorbidity defined from the Emb-LPD model is similar but not identical to a related 
periconceptional model where LPD is restricted exclusively to the period of oocyte maturation before 
fertilisation (Watkins, Wilkins et al. 2008). 
 
The most revealing postnatal Emb-LPD phenotype is an altered body weight profile since this has 
allowed an understanding both of the origins of adult diseases and the derivation of the altered 
developmental programming from the preimplantation period onwards. As in the rat model, postnatal 
excess growth, synonymous to the ‘catch-up’ growth recorded across the DOHaD literature (Barker, 
Osmond et al. 2009; Langley-Evans 2014), is evident in response to maternal Emb-LPD but in the 
mouse this occurs earlier than in the rat resulting in increased birthweight for male and female offspring 
combined and increased body weight gain for females alone (Watkins, Ursell et al. 2008). Thus, fetal 
growth is stimulated in late gestation in mouse Emb-LPD pregnancies, leading to increased birthweight 
and likely representing a compensatory response to poor maternal nutrition. Critically, the increased 
weight evident at birth following Emb-LPD appeared an effective biomarker of future disease, 
correlating positively with weight, systolic blood pressure and behavioural dysfunction in adulthood 
(Watkins, Ursell et al. 2008). In female Emb-LPD offspring, the weight advantage at birth is maintained 
through to adulthood compared to NPD controls but in males, perhaps through appetite regulation, 
postnatal weight becomes equivalent to controls (Watkins, Ursell et al. 2008). 
 
Emb-LPD adult disease: the link to preimplantation environment 
The comorbidity following maternal Emb-LPD in mice broadly matches the combination of non-
communicable disease conditions found in the wider literature of rodent maternal LPD sustained 
throughout the gestation period (Langley-Evans 2001; Langley-Evans 2013; Watkins, Ursell et al. 
2008). This clearly suggests that periconceptional development may be the major period of 
susceptibility to maternal dietary programming affecting lifelong health. The human epidemiological 
datasets associated with the Dutch Hunger Winter substantiate this and show that persons conceived 
during the famine (rather than ‘experienced’ it during later gestation) exhibit in adulthood a doubled rate 
of coronary heart disease, a more  atherogenic plasma lipid profile, increased risk of schizophrenia and 
depression, were more responsive to stress and performed worse in cognitive tasks, collectively a sign 
of accelerated ageing (Roseboom, Painter et al. 2011). The simple conclusion is that the earlier maternal 
nutritional deprivation occurs during development the more widespread and critical the disease 
condition in adult life. 
 
This periconceptional sensitivity may reflect the small number of totipotent and becoming pluripotent 
cells in the embryo, the co-occurrence of embryonic and extra-embryonic cell lineage allocation, and the 
extensive epigenetic restructuring that characterises this period. Such a combination of circumstances 
provides an opportunity for the embryo to optimise its future developmental programme according to 
environmental conditions, a form of plasticity consistent with the predictive adaptive responses concept 
in DOHaD (Gluckman and Hanson 2004). It also identifies a vulnerability for the embryo in that the 
entirety of subsequent conceptus lineages will be subject to this plasticity (Eckert and Fleming 2011). 
To understand why periconceptional maternal undernutrition has such a profound effect on adult health 
 requires knowledge of the sequence of events from the time of maternal dietary intervention, whether 
and how the embryo may perceive dietary quality, and how the embryo may express plasticity and 
change its pattern of development as a consequence (Figure 2). In this review, we argue that early 
embryos make ‘decisions’ based upon their environment that can ultimately control their metabolic 
homeostasis and adult disease risk. 
 Embryo sensing of maternal dietary quality 
The rat and mouse Emb-LPD models have been shown to lead to depleted levels of insulin and amino 
acids, particularly the branched chain amino acids (BCAAs), leucine, isoleucine and valine, within 
maternal serum during the period of blastocyst morphogenesis (Kwong, Wild et al. 2000; Watkins, 
Ursell et al. 2008). We consider this dietary effect as significant since insulin and BCAAs are key 
activators of cellular growth through the mTORC1 signalling pathway (Dowling, Topisirovic et al. 
2010; Proud 2007; Wang and Proud 2009).  Moreover, insulin and BCAAs have been shown to have 
stimulatory effects on preimplantation embryo biosynthetic activity, cell proliferation and endocytosis, 
with enduring effects on fetal growth (Dunglison, Jane et al. 1995; Harris, Gopichandran 220 et al.  
2005; Heyner 1997; Kaye and Gardner 1999; Kaye and Harvey 1995; Lane and Gardner 1997; Martin, 
Sutherland et al. 2003) and blastocysts are known to utilise mTORC1 signalling to regulate 
trophectoderm motility (Gonzalez, Martin et al. 2012; Martin and Sutherland 2001).  To substantiate the 
potential significance of Emb-LPD changes on in maternal serum, we investigated BCAA 
concentrations in uterine fluid during the time of blastocyst formation and expansion. This study 
demonstrated a ~25-30% depletion of all three BCAAs in Emb- LPD versus NPD uterine fluid (Eckert, 
Porter et al. 2012). 
 
 Whilst this provides good circumstantial evidence that maternal insulin and BCAA concentrations may 
act as metabolic factors important in Emb-LPD programming, it is important to establish whether 
blastocyst mTORC1 signalling is sensitive to this change and altered in response to the dietary 
challenge. Critically, we have found that the mTORC1  downstream target S6 ribosomal protein, a 
translational activator of terminal  oligopyrimidine-dependent transcripts encoding ribosomal proteins 
active in protein  translation and cell cycling (Kim 2009; Peterson and Schreiber 1998), was 
significantly  deactivated in blastocysts in response to Emb-LPD, exhibiting a reduced  
phosphorylation:total protein ratio in quantitative immunoblots (Eckert, Porter et al. 2012).  This direct 
evidence of altered mTORC1 signalling in Emb-LPD blastocysts coincident with depleted maternal 
insulin and BCAA availability leads us to conclude that this pathway is utilised for nutrient sensing in 
vivo. This conclusion is further substantiated by the fact that blastocyst amino acid composition is 
quantifiably altered by the maternal Emb-LPD diet with five being significantly altered and 17 out of 19 
amino acids analysed showing a reduced mean concentration following Emb-LPD treatment (Eckert, 
Porter et al. 2012). 
 
From embryo sensing to altered developmental programming 
How might the maternal-embryonic interaction occurring through metabolite concentration downstream 
of dietary composition lead to altered developmental programming? Is the metabolic change detected 
within the Emb-LPD blastocyst sufficient for programming to occur? We have transferred Emb-LPD 
and NPD blastocysts into opposite horns of NPD recipients to test this possibility. We have found that 
transferred Emb-LPD blastocysts develop into significantly heavier conceptuses in late gestation 
compared with transferred NPD blastocysts within an NPD maternal environment, providing compelling 
evidence that the blastocyst stage becomes programmed for an altered growth trajectory independent of 
the  subsequent maternal dietary environment (Watkins, Ursell et al. 2008). Moreover, culturing 
embryos throughout cleavage in medium with reduced insulin and BCAAs as in Emb-LPD mothers can 
lead to altered postnatal growth and increased blood pressure similar to Emb-  LPD offspring 
(Velazquez, Sheth et al. 2014). We consider this as critical evidence that the blastocyst mTORC1 
sensing of deficient insulin/BCAA composition is the mechanism activating adverse long-term 
programming. 
 
 From embryo programming to compensatory fetal growth 
 If the reduction in maternal nutrient availability sensed by the Emb-LPD blastocyst via mTORC1 
signalling programmes an increased fetal growth trajectory, can we identify how this compensatory 
response is mediated? We have studied the extra-embryonic lineages in our mouse Emb-LPD model to 
find such evidence (Figures 2 and 3). Could plasticity in the  maturation of these lineages, both 
trophectoderm as progenitor of the chorio-allantoic  placenta, and primitive endoderm as progenitor of 
the visceral yolk sac placenta, provide a  physiological mechanism to link poor maternal diet with 
increased efficiency in maternal- embryonic/fetal nutrient delivery to drive fetal growth? Indeed, our 
recent 269 studies provide several lines of evidence for compensatory responses within the extra-
embryonic lineages. 
 
Compensation within trophectoderm lineage: 
Cellular studies on the mouse Emb-LPD blastocyst have shown that the trophectoderm (TE) lineage is 
stimulated through increased proliferation relative to the inner cell mass (ICM). Increased proliferation 
within the Emb-LPD TE leads to increased total cells within the blastocyst at E3.75 (Eckert, Porter et al. 
2012). In our rat Emb-LPD model, blastocyst TE numbers were unchanged in the early blastocyst but 
declined in the late blastocyst, an inconsistency with the mouse that may associate with the delay in 
compensatory growth in the rat until after birth (Kwong, Wild et al. 2000). The mouse Emb-LPD 
blastocyst TE further shows evidence of increased endocytosis as a compensatory response, reflecting 
an increase in nutrient quantity internalised in conditions of reduced nutrient quality (Sun, Velazquez et 
al. 2014). The stimulation in endocytosis is comprehensive and comprises increased number and/or 
volume of endocytosed vesicles and lysosomes, together with increased expression and vesicular 
distribution of the major endocytic receptor in TE, the megalin LDL-family receptor (Assemat, Vinot et 
al. 2005; Gueth-Hallonet, Santa-Maria et al. 1994; Moestrup and Verroust 2001; Sun, Velazquez et al. 
 2014). In vitro studies further demonstrated compensatory endocytosis was stimulated through reduced 
environmental protein concentration, as shown previously (Dunglison and Kaye 1995) and was induced 
rapidly upon protein deprivation yet was sustained even if environmental protein was restored. 
Moreover, stimulated endocytosis could be activated specifically by mimicking in vitro the reduced 
insulin and BCAA levels found in Emb-LPD mothers (Sun, Velazquez et al. 2014), thereby showing 
mechanistic continuity between the dietary challenge and embryo response. This cell biological 
response to poor 294 maternal diet is regulated downstream from insulin/BCAA signalling via the actin 
cytoskeleton, specifically mediated through activation of the RhoA small GTPase which can modulate 
actin polymerisation (Bohdanowicz and Grinstein 2013; Garred, Rodal et al. 2001). Thus, specific 
inhibition of RhoA GTPase in Emb-LPD blastocysts was able to inhibit stimulation of endocytosis (Sun, 
Velazquez et al. 2014). The stimulation of TE endocytosis by maternal Emb-LPD had no effect on 
cellular autophagy suggesting the response was focused on retrieving more extracellular nutrients 
present in the uterine fluid rather than increasing cellular catabolism (Sun, Velazquez et al. 2014). 
 
A final compensatory response mediated by Emb-LPD blastocyst TE was increased motility and 
invasiveness of the primary trophoblast cells that emerge at the time of implantation after hatching from 
the zona pellucida. In an in vitro outgrowth model of Emb-LPD blastocysts, the area of trophoblast 
migration per unit time was significantly increased versus NPD blastocysts (Eckert, Porter et al. 2012). 
Collectively, we consider these three responses detected within mouse Emb-LPD blastocyst TE, of 
increased proliferation, increased endocytosis of extracellular fluid and stimulated outgrowth motility 
and invasiveness phenotype, represent developmental plasticity and the capacity to enhance nutrient 
uptake during gestation despite maternal protein restriction. Indeed, recent studies show the placenta of 
LPD mice during later gestation exhibit morphological and functional adaptations to optimise nutrient 
transfer to the fetus, consistent with the early extra-embryonic mechanisms described above (Coan, 
Vaughan et al. 2011). 
 
Compensation within primitive endoderm lineage 
The primitive endoderm (PE) forms on the blastocoel face of the ICM in 318 the expanding late 
blastocyst and is the progenitor of the visceral endoderm epithelial layer of the yolk sac. The yolk sac 
regulates histiotrophic nutrition through endocytosis and lysosomal breakdown of maternal uterine 
lumen proteins and the delivery of liberated amino acids for post implantation embryo growth, 
particularly before the chorio-allantoic placenta is functional (Beckman, Lloyd et al. 1997; Bloomfield, 
Jaquiery et al. 2013; Zohn and Sarkar 2010). Our analyses of Emb-LPD extra-embryonic PE lineage 
compensatory responses have shown some similarities with TE responses. Thus, both PE and its visceral 
endoderm derivative in later gestation exhibit stimulated endocytosis. We have used mouse embryonic 
stem cell (mESC) lines derived from Emb-LPD and NPD blastocysts cultured to form embryoid bodies 
in which a PE forms of the surface to assess endocytic activity. Like TE within earlier blastocyst stages, 
the PE in embryoid bodies show increased ligand uptake, cellular lysosomes and megalin receptor 
expression compared with NPD embryoid bodies (Sun, Velazquez et al. 2014). During later gestation, 
ex vivo LPD or Emb-LPD yolk sac visceral endoderm exhibited increased endocytosis of exogenous 
radiolabelled tracer, increased numbers of endocytic vesicles at the ultrastructural level, and increased 
megalin protein expression (Watkins, Ursell et al. 2008). Emb-LPD embryoid bodies grew to a larger 
size per unit time than NPD embryoid bodies, suggesting that Emb-LPD PE cells may also undergo 
increased proliferation (Sun, Denisenko et al. 2015) (Sun, Denisenko et al. 2014). 
 
Epigenetic regulation of the Emb-LPD PE phenotype 
The extra-embryonic lineage compensatory responses indicate true programming characteristics in that 
they are maintained irrespective of whether the initiating stimulus (Emb-LPD) is preserved. For 
example TE or PE stimulated endocytosis following Emb-LPD is retained in standardised culture 
medium and, in the case of PE, even after mESC derivation and culture over several passages in 
standard culture medium. The persistence of these responses indicates epigenetic regulation to retain 
altered levels of gene expression. The Emb-LPD embryoid body model has allowed us to investigate 
epigenetic regulation of Emb- LPD developmental programming. We found that Emb-LPD embryoid 
bodies, despite growing to a larger size than NPD embryoid bodies, had reduced expression at gene and 
protein levels of the transcription factor Gata6 (Sun, Denisenko et al. 2014) (Sun, Denisenko et al. 
2015), known to be the key regulator of PE differentiation (Artus, Piliszek et al. 2011; Rossant, 
Chazaud et al. 2003; Schrode, Saiz et al. 2014). Previously, suppression of Gata6 expression has been 
shown to coincide with increased proliferation and reduced differentiation of several ovarian carcinoma 
cell lines (Cai, Caslini et al. 2009; Caslini, Capo chichi et al. 2006) and reduced Gata6 expression 
occurs in ex vivo Emb-LPD yolk sacs, all  indicating a role in stimulating proliferation and suppressing 
differentiation in our Emb-LPD model. We have compared histone modifications of the Gata6 promoter 
within Emb-LPD and NPD embryoid bodies using chromatin immunoprecipitation assay and found 
significant reduction in histone H3 and H4 acetylation and RNA polymerase II binding in the Emb-LPD 
Gata6 promoter, all markers of reduced transcription. In addition, the histone deacetylase Hdac-1gene 
expression was upregulated in Emb-LPD embryoid bodies which may drive the deacetylation of the 
Gata6 promoter and contribute to reduced expression of the gene (Sun, Denisenko et al. 2015)(Sun, 
Denisenko et al. 2014). 
 
Conclusions 
The maternal Emb-LPD model has demonstrated a clear association and sequence of events linking 
maternal dietary consumption during the periconceptional period and adult onset non communicable 
disease. We find diet changes the composition of maternal fluids including within the uterine lumen and 
that embryos residing there can sense the quality of these nutrients, in this case via BCAA and insulin 
levels and the mTOR signalling pathway. This information, we propose, allows little embryos (<100 μm 
diameter) to make some big and apparently permanent decisions leading to adverse programming of 
adult health. This occurs even if the embryo is transferred to a mother having normal nutrition 
throughout. We find some key decisions are to activate a series of compensatory responses within both 
the trophectoderm and primitive endoderm pathways of the extra-embryonic lineages. The 
compensations are designed to improve nutrient delivery from the mother to overcome the deficiency of 
low nutrient quality. Such a response is effective in protecting fetal growth and likely reflects an 
evolutionary mechanism to retain reproductive fitness of offspring. The trade-off, however, is an 
increased risk of adult onset disease with less evolutionary significance. We need to develop maternal 
nutrient supplementation strategies to alleviate the risk of reduced protein availability during 
periconceptional life. 
 
One interesting aspect of the response to maternal undernutrition within our model is the gender 
specificity evident in particular postnatally with female offspring showing more severe growth and 
behavioural consequences (Watkins, Ursell et al. 2008). In other animal based, maternal dietary models 
focussed on the periconceptional period, gender-specific cardiometabolic or growth phenotype 
differences have been observed in offspring (Bermejo- Alvarez, Rizos et al. 2011; Sinclair, Allegrucci et 
al. 2007). Similarly, in ART-related embryo environment models, sexual dimorphism in embryo 
survival and adult offspring phenotype has been recorded (Fernandez-Gonzalez, Moreira et al. 2004; 
Feuer, Donjacour et al. 2014; Sjoblom, Roberts et al. 2005; Tarin, Garcia-Perez et al. 2014). Why might 
this occur following dietary challenge at the preimplantation stage? Differing environmental sensitivities 
by male and female embryos before gonadal development and direct sex hormone effects can be 
influential most likely derive from sex chromosome dosage effects on transcriptional activity (Bermejo-
Alvarez, Rizos et al. 2011). Downstream from transcriptional differences, gender-specific variance in 
metabolism and growth rates may emerge in response to environmental challenge (Bermejo-Alvarez, 
Rizos et al. 2011; Erickson 1997), and this may be substantiated by X-inactivation in females (Tarin, 
Garcia- Perez et al. 2014) and by sex hormone effects during subsequent fetal development. The 
emergence and propagation of sexual dimorphic responses to dietary challenge from the preimplantation 
period onwards will be one important direction for future research. 
 
Do little embryos make big decisions about other forms of their early environment? We know from 
another mouse model we have developed that maternal bacterial infection around the time of 
conception, mimicked by a single intraperitoneal injection of bacterial endotoxin, activated changes in 
blastocyst cellular organisation and alters offspring phenotype irreversibly (Williams, Teeling et al. 
2011). However, here, the periconceptional endotoxin treatment does not alter the cardiometabolic 
phenotype of the adult offspring but rather suppresses the innate immune system after challenge, 
perhaps a programming mechanism to protect itself from a perceived pathogen-rich environment and the 
risk of auto-immune disease (Williams, Teeling et al. 2011). This argues that the early embryo does not 
activate a single stress-related response to diverse environmental challenges but rather is more selective, 
using the cues provided to optimise its future development through epigenetic and physiological 
mechanisms of plasticity – the embryo has its own agenda distinct from its mother and father. There is 
growing evidence that assisted reproductive treatments (ART) can lead to small but increased risk of 
disease in children (Hart and Norman 2013a; Hart and Norman 2013b). We are still uncertain how the 
embryo ‘views’ its culture medium and the nature of potential compensatory responses that might 
unfold. However, the lessons from the Emb-LPD model suggest that the sequence of events should be 
further explored to protect against unwelcome disease effects. 
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Figure legends 
Figure 1. Schematic representation of mouse maternal Emb-LPD dietary model treatment. Control and 
treated females are fed with 18% (NPD) or 9% casein (LPD) respectively from the time of detection of 
the copulatory plug in the morning following natural mating (embryonic day 0.5 [E0.5]) and for the 
duration of pregnancy. A second treatment group is fed 9% casein (Emb-LPD) exclusively from the 
time of detection of the copulatory plug until blastocyst formation (E3.5) before switching to NPD for 
the remainder of the pregnancy. This latter group allows addressing the importance of the 
preimplantation period in nutritional programming. Before weaning, dams and offspring are fed with 
standard chow. At weaning, offspring continues on chow diet until the end of the experiment. 
 
Figure 2. Proposed model depicting the short- and long-term effects of low protein exposure 
exclusively during in vivo preimplantation embryo development in the mouse (an olyovulatory species). 
Protein undernutrition can decrease concentrations of insulin in blood and amino acids (AA) in both 
blood and in uterine luminal fluid (ULF) respectively, which in turn induces cellular and molecular 
changes in both the blastocyst 442 and the conceptus. These changes are associated with an enhanced 
nutrient intake uptake during in utero, with long-lasting consequences in adult life. The altered 
phenotype observed during postnatal development can be sex-specific. Model based on data from 
Watkins et al . (2008), Eckert et al. (2012) and Sun et al. (2014). 
 
Figure 3. In vitro model to study the effects of protein undernutrition during the preimplantation period 
on trophoblast and primitive endoderm activity. Blastocysts are collected from females fed with 9% 
casein (Emb-LPD) exclusively during preimplantation embryo development and used for blastocyst 
outgrowth and embryoid body production. These studies have revealed an increased motility of the 
trophoblast and enhanced endocytic activity in embryoid bodies associated with decreased expression of 
important transcription factors (i.e. Gata6) critical for primitive endoderm formation. 
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